The growth of Roche’s diagnostics division flipped the decline observed since 2017, accelerated primarily by the COVID-19 pandemic as it released a plethora of rapid testing kits.
Roche announced its first quarter earnings on 21 April. Group sales were up 3% at constant exchange rates. This was,...